港股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

泰德醫藥

22.720

-0.440-1.90%

成交量：8.58萬

成交額：196.34萬

市值：32.22億

市盈率：11.95

高：23.240

開：23.160

低：22.560

收：23.160

52周最高：41.300

52周最低：19.000

股本：1.42億

香港流通股本：1.42億

量比：1.03

換手率：0.06%

股息：- -

股息率：- -

每股收益(LYR):1.901

淨資產收益率：22.84%

總資產收益率：8.84%

市淨率：1.74

市盈率(LYR):11.95

市銷率: 4.85

資料載入中...

總覽公司新聞資訊公告

泰德醫藥(03880)股價上升5.722%，現價港幣$23.28

阿斯达克财经

泰德醫藥(03880.HK)擬8月27日舉行董事會會議以審批中期業績

泰德醫藥(03880)擬於2026年8月27日召開董事會審議2026年中期業績

港股CXO近日股價集體走高，盈警之後的泰德醫藥(03880)將逆市下跌還是超跌反彈？

泰德醫藥7月股份變動月報表，股本維持穩定

泰德醫藥(03880)成功完成HEPCLUDEX®原料藥之美國FDA上市許可前檢查(PLI)

泰德醫藥(03880)發盈警預計上半年利潤按年減少約44%至51.6%

泰德醫藥（03880）發布高管調整：丁麗君出任首席財務官併兼任董事會秘書同時更新港辦地址

泰德醫藥(03880)：丁麗君獲委任為首席財務官

泰德醫藥（03880）發布盈利警告：預計2026年中期利潤最多下滑逾五成

泰德醫藥（03880）全資子公司通過美國FDA上市許可前檢查

泰德醫藥更新6月股份變動月報表，股本維持穩定

泰德醫藥(03880)股價下跌5.792%，現價港幣$22.12

阿斯达克财经

泰德醫藥(03880)附屬與Market One Builders 訂立建設合約以建設羅克林園區

泰德醫藥5月無新增發行或股份變動

泰德醫藥獲授權回購不超過已發行股份10%

泰德醫藥4月股份變動月報表：股本維持不變

泰德醫藥：2025年淨利潤按年增長267.3%

南方财经网

泰德醫藥更新2026年3月股份變動月報表，股本增至141,800,000股

泰德醫藥(03880.HK)擬3月30日召開董事會會議審批年度業績

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/03880/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"03880","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","market":"HK","secType":"STK","nameCN":"泰德醫藥","latestPrice":22.72,"timestamp":1787640818602,"preClose":23.16,"halted":0,"volume":85800,"delay":0,"changeRate":-0.018998272884283303,"floatShares":141800000,"shares":141800000,"eps":1.900595461137459,"marketStatus":"交易中","change":-0.44,"latestTime":"08-25 14:58:19","open":23.16,"high":23.24,"low":22.56,"amount":1963354,"amplitude":0.029361,"askPrice":22.8,"askSize":100,"bidPrice":22.64,"bidSize":800,"shortable":0,"etf":0,"ttmEps":1.9787180966566063,"tradingStatus":2,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787645400000},"marketStatusCode":2,"adr":0,"listingDate":1751212800000,"exchange":"SEHK","adjPreClose":23.16,"openAndCloseTimeList":[[1787621400000,1787630400000],[1787634000000,1787644800000]],"volumeRatio":1.026692,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"03880\",,,,,undefined,":{"symbol":"03880","floatShares":141800000,"roa":"8.84%","roe":"22.84%","lyrEps":1.900595,"volumeRatio":1.026692,"shares":141800000,"dividePrice":0,"high":23.24,"amplitude":0.029361,"preClose":23.16,"low":22.56,"week52Low":19,"pbRate":"1.74","psRate":"4.85","week52High":41.3,"institutionHeld":0,"latestPrice":22.72,"committee":0.777778,"eps":1.900595461137459,"divideRate":0,"volume":85800,"delay":0,"ttmEps":1.9787180966566063,"open":23.16,"prevYearClose":30.48,"prevWeekClose":23.34,"prevMonthClose":22.52,"prevQuarterClose":22.08,"fiveDayClose":23.28,"twentyDayClose":23,"sixtyDayClose":21.74,"earningDate":1787760000000},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/03880\",params:#limit:5,,,undefined,":[{"date":"2026-08-27","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1787794200000,"name":null,"time":"","dateTimestamp":1787760000000,"actualEps":null},{"date":"2026-03-30","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1774834200000,"name":null,"time":"","dateTimestamp":1774800000000,"actualEps":null},{"date":"2025-08-29","symbol":"03880","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756431000000,"name":null,"time":"","dateTimestamp":1756396800000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"03880\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"03880\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":1,"sell":0,"strongSell":0,"meanLabel":"HOLD","meanPercent":1,"analysts":1,"updateTime":1754582400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/03880\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"03880","date":"2026-08-24","current":11.401142,"percent":0.261484,"low":11.049775,"twenty":12.634902,"median":31.848887,"eighty":38.092156,"high":89.502411,"avg":33.026175,"sd":21.495386,"marketCap":3284088000},"quantilePoints":[{"date":"2025-06-27","current":64.550519,"twenty":64.550519,"median":64.550519,"eighty":64.550519,"marketCap":4183100000},{"date":"2025-07-04","current":69.032987,"twenty":66.795355,"median":68.595377,"eighty":69.313609,"marketCap":4473790000},{"date":"2025-07-11","current":68.445519,"twenty":67.311524,"median":68.276633,"eighty":68.994281,"marketCap":4431250000},{"date":"2025-07-18","current":76.171108,"twenty":67.389311,"median":68.984604,"eighty":75.214843,"marketCap":4927550000},{"date":"2025-07-25","current":74.03868,"twenty":67.965697,"median":71.906475,"eighty":74.616858,"marketCap":4807020000},{"date":"2025-08-01","current":77.026259,"twenty":68.377965,"median":73.828208,"eighty":76.342138,"marketCap":4970090000},{"date":"2025-08-08","current":73.611635,"twenty":68.565405,"median":73.719922,"eighty":75.214843,"marketCap":4761644000},{"date":"2025-08-15","current":78.991101,"twenty":68.906759,"median":73.83709,"eighty":76.342138,"marketCap":5101964000},{"date":"2025-08-22","current":89.502411,"twenty":69.02331,"median":74.090002,"eighty":78.320217,"marketCap":5762752000},{"date":"2025-08-29","current":78.512395,"twenty":70.155476,"median":74.257083,"eighty":79.74991,"marketCap":5079276000},{"date":"2025-09-05","current":41.646228,"twenty":68.906759,"median":74.188856,"eighty":79.74991,"marketCap":5031064000},{"date":"2025-09-12","current":37.986037,"twenty":67.389311,"median":74.066692,"eighty":79.087699,"marketCap":4597156000},{"date":"2025-09-19","current":35.879032,"twenty":42.439428,"median":73.832649,"eighty":78.741923,"marketCap":4339080000},{"date":"2025-09-26","current":35.972365,"twenty":39.207677,"median":73.603619,"eighty":78.545842,"marketCap":4339080000},{"date":"2025-10-03","current":36.895298,"twenty":38.254613,"median":73.439791,"eighty":78.477782,"marketCap":4461028000},{"date":"2025-10-10","current":35.939087,"twenty":37.926552,"median":73.260895,"eighty":78.387462,"marketCap":4339080000},{"date":"2025-10-17","current":35.261849,"twenty":36.980504,"median":69.008796,"eighty":78.069934,"marketCap":4254000000},{"date":"2025-10-24","current":35.954012,"twenty":36.188249,"median":68.445519,"eighty":77.701013,"marketCap":4339080000},{"date":"2025-10-31","current":35.900465,"twenty":36.021695,"median":67.397498,"eighty":77.513348,"marketCap":4339080000},{"date":"2025-11-07","current":35.922904,"twenty":35.979492,"median":65.840942,"eighty":76.855229,"marketCap":4339080000},{"date":"2025-11-14","current":36.196001,"twenty":35.973277,"median":41.646228,"eighty":76.009632,"marketCap":4384456000},{"date":"2025-11-21","current":32.839875,"twenty":35.967307,"median":40.069862,"eighty":75.286139,"marketCap":3976072000},{"date":"2025-11-28","current":33.374508,"twenty":35.955467,"median":38.580928,"eighty":74.943808,"marketCap":4055480000},{"date":"2025-12-05","current":32.851251,"twenty":35.944759,"median":38.254067,"eighty":74.758171,"marketCap":3998760000},{"date":"2025-12-12","current":33.023157,"twenty":35.900465,"median":37.886895,"eighty":74.473119,"marketCap":4027120000},{"date":"2025-12-19","current":34.430381,"twenty":35.39442,"median":37.394857,"eighty":74.229792,"marketCap":4208624000},{"date":"2025-12-24","current":34.99421,"twenty":35.141853,"median":37.085683,"eighty":74.147921,"marketCap":4290868000},{"date":"2026-01-02","current":33.635992,"twenty":35.029056,"median":36.743987,"eighty":74.11624,"marketCap":4140560000},{"date":"2026-01-09","current":32.725127,"twenty":34.456149,"median":36.454304,"eighty":74.08534,"marketCap":4038464000},{"date":"2026-01-16","current":32.687847,"twenty":33.647972,"median":36.236629,"eighty":74.049885,"marketCap":4046972000},{"date":"2026-01-23","current":31.091299,"twenty":33.318703,"median":36.073206,"eighty":73.917726,"marketCap":3845616000},{"date":"2026-01-30","current":31.269354,"twenty":33.177249,"median":36.016394,"eighty":73.831761,"marketCap":3885320000},{"date":"2026-02-06","current":27.433753,"twenty":32.966335,"median":35.983345,"eighty":73.698264,"marketCap":3417380000},{"date":"2026-02-13","current":29.767101,"twenty":32.846701,"median":35.969241,"eighty":73.606825,"marketCap":3729340000},{"date":"2026-02-20","current":29.696692,"twenty":32.725127,"median":35.967659,"eighty":73.603619,"marketCap":3715160000},{"date":"2026-02-27","current":28.724265,"twenty":32.439619,"median":35.961022,"eighty":73.603001,"marketCap":3632916000},{"date":"2026-03-06","current":25.544273,"twenty":32.105235,"median":35.955322,"eighty":73.439791,"marketCap":3204680000},{"date":"2026-03-13","current":25.719686,"twenty":31.941403,"median":35.950844,"eighty":73.376851,"marketCap":3241548000},{"date":"2026-03-20","current":24.620311,"twenty":31.419436,"median":35.939087,"eighty":73.260895,"marketCap":3091240000},{"date":"2026-03-27","current":25.407751,"twenty":30.961293,"median":35.900465,"eighty":70.436098,"marketCap":3181992000},{"date":"2026-04-02","current":12.694395,"twenty":30.374151,"median":35.877946,"eighty":69.313609,"marketCap":3139452000},{"date":"2026-04-10","current":12.836208,"twenty":29.799581,"median":35.844414,"eighty":69.013634,"marketCap":3199008000},{"date":"2026-04-17","current":12.660198,"twenty":28.991894,"median":35.202659,"eighty":68.828913,"marketCap":3156468000},{"date":"2026-04-24","current":12.397874,"twenty":27.75939,"median":35.115214,"eighty":68.535434,"marketCap":3091240000},{"date":"2026-04-30","current":12.269611,"twenty":26.785787,"median":34.99421,"eighty":68.377965,"marketCap":3060044000},{"date":"2026-05-08","current":12.363155,"twenty":25.983648,"median":34.594549,"eighty":67.965697,"marketCap":3094076000},{"date":"2026-05-15","current":12.534163,"twenty":25.665008,"median":34.175169,"eighty":67.389311,"marketCap":3145124000},{"date":"2026-05-22","current":12.642172,"twenty":25.399381,"median":33.645975,"eighty":67.311524,"marketCap":3164976000},{"date":"2026-05-29","current":12.270986,"twenty":25.218458,"median":33.406025,"eighty":67.131365,"marketCap":3082732000},{"date":"2026-06-05","current":11.125953,"twenty":24.642571,"median":33.30501,"eighty":64.550519,"marketCap":2799132000},{"date":"2026-06-12","current":13.017265,"twenty":13.007169,"median":33.187074,"eighty":42.637728,"marketCap":3272744000},{"date":"2026-06-18","current":12.671021,"twenty":12.943368,"median":33.126975,"eighty":41.844528,"marketCap":3193336000},{"date":"2026-06-26","current":12.518344,"twenty":12.901138,"median":33.023157,"eighty":41.133711,"marketCap":3139452000},{"date":"2026-07-03","current":12.429887,"twenty":12.724861,"median":32.858736,"eighty":40.911062,"marketCap":3119600000},{"date":"2026-07-10","current":13.463401,"twenty":12.685266,"median":32.845563,"eighty":39.914225,"marketCap":3374840000},{"date":"2026-07-17","current":13.021079,"twenty":12.724861,"median":32.687847,"eighty":39.039678,"marketCap":3275580000},{"date":"2026-07-24","current":12.950528,"twenty":12.774507,"median":32.49883,"eighty":38.697228,"marketCap":3258564000},{"date":"2026-07-31","current":12.667228,"twenty":12.718655,"median":32.350921,"eighty":38.507791,"marketCap":3193336000},{"date":"2026-08-07","current":11.576024,"twenty":12.668745,"median":32.105235,"eighty":38.341571,"marketCap":2923916000},{"date":"2026-08-14","current":12.133289,"twenty":12.639428,"median":31.958711,"eighty":38.254613,"marketCap":3068552000},{"date":"2026-08-21","current":13.057601,"twenty":12.633554,"median":31.917498,"eighty":38.145216,"marketCap":3309612000},{"date":"2026-08-24","current":12.961566,"twenty":12.634902,"median":31.848887,"eighty":38.092156,"marketCap":3284088000}],"updateTime":1787631066530},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"03880\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660468536","title":"泰德醫藥(03880)股價上升5.722%，現價港幣$23.28","url":"https://stock-news.laohu8.com/highlight/detail?id=2660468536","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660468536?lang=zh_tw&edition=fundamental","pubTime":"2026-08-18 15:59","pubTimestamp":1787039940,"startTime":"0","endTime":"0","summary":"[上升股]泰德医药(03880) 股价在下午03:58比前收市价上升5.722%，现股价为港币$23.28。至目前为止，今日最高价为$23.28，而最低价为$21.8。总成交量为10.28万股，总成交金额为港币$228.388万。","market":"other","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20190515141040914_s.png"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182748/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAR2608182748/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660348657","title":"泰德醫藥(03880.HK)擬8月27日舉行董事會會議以審批中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2660348657","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660348657?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 17:17","pubTimestamp":1786958230,"startTime":"0","endTime":"0","summary":"格隆汇8月17日丨泰德医药(03880.HK)公告，董事会会议将于2026年8月27日(星期四)召开，藉以(其中包括)审议及批准公司及其附属公司截至2026年6月30日止6个月的中期业绩及其刊发。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260817/32337228.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162717331","title":"泰德醫藥(03880)擬於2026年8月27日召開董事會審議2026年中期業績","url":"https://stock-news.laohu8.com/highlight/detail?id=1162717331","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162717331?lang=zh_tw&edition=fundamental","pubTime":"2026-08-17 16:36","pubTimestamp":1786955818,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司（03880）8月17日公告称，公司董事会计划于2026年8月27日（星期四）召开会议，届时将审议并批准公司及其附属公司截至2026年6月30日止六个月的中期业绩及其发布事宜。  \n  \n公告显示，董事会现由执行董事徐琪博士（兼董事长兼首席执行官）、李湘博士、李湘莉女士、Cheng Tao女士及李玲梅女士；非执行董事吴一晖先生；以及独立非执行董事于常海博士、朱迅博士、夏心晟先生组成。  \n  \n公司未在公告中披露任何财务数据。待董事会审议通过后，相关中期业绩将另行发布。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657698357","title":"港股CXO近日股價集體走高，盈警之後的泰德醫藥(03880)將逆市下跌還是超跌反彈？","url":"https://stock-news.laohu8.com/highlight/detail?id=2657698357","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657698357?lang=zh_tw&edition=fundamental","pubTime":"2026-08-07 10:22","pubTimestamp":1786069332,"startTime":"0","endTime":"0","summary":"7月31日盘后，泰德医药发布了其26H1财年盈警公告。目前泰德医药尚未迎来连续数个交易日的低点逐步抬高以彻底终结下跌趋势，关键的量能均线也尚未出现明显转折。近日，港股医药概念股集体走高，CXO、创新药板块多点爆发，带动恒生医疗保健指数强势反弹。以8月4日行情为例，港股CXO板块出现一波个股集体走高，其中药明康德股价大涨11.17%，康龙化成和泰格医药均涨超5%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1477144.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["WX","03880","BK1141","BK4588","CXO","BK4585","NIFE","VXUS","KCAI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1169061968","title":"泰德醫藥7月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1169061968","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1169061968?lang=zh_tw&edition=fundamental","pubTime":"2026-08-05 16:51","pubTimestamp":1785919909,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司于2026年8月5日发布2026年7月股份变动月报表，报告期为截至2026年7月31日。公告显示，公司普通股H股的已发行股本数量和注册股本在报告期内均维持不变。报告期内，公司无新增发行、购回、注销或库藏股活动，已发行股份及库存股份数目稳定在141,800,000股和0股，符合香港联合交易所有限公司关于最低公众持股量的相关规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655562893","title":"泰德醫藥(03880)成功完成HEPCLUDEX®原料藥之美國FDA上市許可前檢查(PLI)","url":"https://stock-news.laohu8.com/highlight/detail?id=2655562893","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655562893?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:39","pubTimestamp":1785487145,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药 发布公告，公司全资附属公司中肽生化有限公司位于中国杭州的现行生产质量管理规范生产设施，已成功通过由美国食品及药物管理局开展的上市许可前检查。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474593.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","BK4588","BK4585","03880","LABU","IPOS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356079","title":"泰德醫藥(03880)發盈警 預計上半年利潤按年減少約44%至51.6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356079","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356079?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:38","pubTimestamp":1785487130,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药 发布公告，相较于截至2025年6月30日止六个月的数据，董事会预期截至2026年6月30日止六个月：1.收入将介于约人民币2.298亿元至2.392亿元，同比减少约5.7%至9.4%;2.利润将介于约人民币4940万元至5710万元，同比减少约44.0%至51.6%;3.经调整净利润将介于约人民币5140万元至5930万元，同比减少约43.1%至50.6%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474591.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"泰德医药(03880)发盈警 预计上半年利润同比减少约44%至51.6%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1141","03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148155391","title":"泰德醫藥（03880）發布高管調整：丁麗君出任首席財務官併兼任董事會秘書 同時更新港辦地址","url":"https://stock-news.laohu8.com/highlight/detail?id=1148155391","media":"公告速递","labels":["executive","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1148155391?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:36","pubTimestamp":1785487011,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司7月31日公告，公司董事会已通过多项人事及行政调整，自2026年7月31日起生效。公司委任丁丽君女士为首席财务官，负责集团整体财务战略与管理。丁丽君现年50岁，拥有27年财务、业务规划及财务运营管理经验。公司董事会对辞任的吴东澄先生、李玲梅女士表示感谢，并欢迎新任管理层成员履新。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655356495","title":"泰德醫藥(03880)：丁麗君獲委任為首席財務官","url":"https://stock-news.laohu8.com/highlight/detail?id=2655356495","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655356495?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:36","pubTimestamp":1785487001,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药 发布公告，丁丽君女士已获委任为首席财务官，自2026年7月 31日起生效。丁女士将主要负责本集团的整体财务战略与管理。李女士将继续担任本公司执行董事。自2026年7月31日起，继李女士辞任董事会秘书后，丁女士已获委任为董事会秘书。吴先生及李女士辞任联席公司秘书后，陈桢先生已获委任为本公司公司秘书、授权代表及法律程序代理人，自2026 年7月31日起生效。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1474587.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":"泰德医药(03880)：丁丽君获委任为首席财务官","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168086634","title":"泰德醫藥（03880）發布盈利警告：預計2026年中期利潤最多下滑逾五成","url":"https://stock-news.laohu8.com/highlight/detail?id=1168086634","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168086634?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:36","pubTimestamp":1785486978,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司7月31日发布公告称，根据对截至2026年6月30日止六个月未经审计管理账目的初步审阅，预计主要财务指标将出现下滑。公司预计，2026年中期收入将在约2.298亿元至2.392亿元之间，较2025年中期的约2.538亿元下降约5.7%至9.4%。泰德医药提醒投资者，以上数据基于初步评估，未经审计，实际业绩可能与本公告披露的预期存在差异，公司计划于2026年8月底披露中期业绩。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164817050","title":"泰德醫藥（03880）全資子公司通過美國FDA上市許可前檢查","url":"https://stock-news.laohu8.com/highlight/detail?id=1164817050","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1164817050?lang=zh_tw&edition=fundamental","pubTime":"2026-07-31 16:36","pubTimestamp":1785486961,"startTime":"0","endTime":"0","summary":"2026年7月31日，泰德医药发布自愿公告称，其全资子公司中肽生化有限公司位于杭州的cGMP生产设施已通过美国食品及药物管理局对8.5毫克注射用Hepcludex原料药的上市许可前检查。此前，Hepcludex已于2026年5月22日获得FDA加速批准，成为美国首个也是唯一获批用于治疗慢性丁型肝炎病毒感染的药物。在Hepcludex获批之前，美国尚无FDA批准的HDV治疗方案。\\n\\n泰德医药于2025年在香港联交所主板上市，定位为全球CRDMO企业，业务覆盖美国与中国两地。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146063807","title":"泰德醫藥更新6月股份變動月報表，股本維持穩定","url":"https://stock-news.laohu8.com/highlight/detail?id=1146063807","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146063807?lang=zh_tw&edition=fundamental","pubTime":"2026-07-06 17:09","pubTimestamp":1783328943,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司于2026年7月6日披露2026年6月股份变动月报表。公告显示，截至2026年6月30日，公司总股本保持为141,800,000股，与上月持平。公司已发行H股全部在香港联合交易所上市，未设任何库存股份。此外，公告确认公司目前持有足够的公众持股量，符合香港联合交易所《上市规则》以及相关法律法规有关最低公众持股量的要求。公司表示将继续严格遵守香港联合交易所的上市规则和相关法律法规，加强公司治理和信息披露。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647589322","title":"泰德醫藥(03880)股價下跌5.792%，現價港幣$22.12","url":"https://stock-news.laohu8.com/highlight/detail?id=2647589322","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647589322?lang=zh_tw&edition=fundamental","pubTime":"2026-06-30 10:20","pubTimestamp":1782786000,"startTime":"0","endTime":"0","summary":"[下跌股]泰德医药(03880) 股价在上午10:20比前收市价下跌5.792%，现股价为港币$22.12。至目前为止，今日最高价为$23.48，而最低价为$22.12。总成交量为2.8万股，总成交金额为港币$64.344万。","market":"sh","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20180205152742524_s.jpg"],"rights":{"source":"aastocks_highlight","url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2606301284/aamm-all-category","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aamm-content/AAD2606301284/aamm-all-category","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642460176","title":"泰德醫藥(03880)附屬與Market One Builders 訂立建設合約 以建設羅克林園區","url":"https://stock-news.laohu8.com/highlight/detail?id=2642460176","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642460176?lang=zh_tw&edition=fundamental","pubTime":"2026-06-09 20:47","pubTimestamp":1781009230,"startTime":"0","endTime":"0","summary":"智通财经APP讯，泰德医药 发布公告，于2025年8月7日，本公司全资附属公司CPC Scientific Inc.与Market One Builders 订立建设合约，以建设罗克林园区，保证最高价格为2272.45万美元。罗克林园区亦加强本公司为北美客户提供端到端CRDMO服务的能力，涵盖GMP 合规API生产、分析开发、质量控制放行及稳定性测试，且全部于当地交付。更广泛而言，罗克林园区建立了中国境外第二个生产枢纽，与本公司位于杭州的现有设施互补。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1452198.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰德医药(03880)附属与Market One Builders 订立建设合约 以建设罗克林园区","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105285217","title":"泰德醫藥5月無新增發行或股份變動","url":"https://stock-news.laohu8.com/highlight/detail?id=1105285217","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105285217?lang=zh_tw&edition=fundamental","pubTime":"2026-06-03 16:51","pubTimestamp":1780476697,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司于2026年6月3日发布的2026年5月证券变动月报表显示，截至2026年5月31日，公司未发生新增发行、回购或库存股变动，股本结构保持稳定。截至2026年5月底，公司已满足在香港联交所上市所要求的公众持股量要求。月报同时显示，公司当月无涉及股份期权、权证或其他可转换证券的相关变动，亦未发生其他协议或安排下的股份变动事宜。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136706347","title":"泰德醫藥獲授權回購不超過已發行股份10%","url":"https://stock-news.laohu8.com/highlight/detail?id=1136706347","media":"公告速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1136706347?lang=zh_tw&edition=fundamental","pubTime":"2026-05-27 22:46","pubTimestamp":1779893201,"startTime":"0","endTime":"0","summary":"泰德医药日前在公告中披露，董事会已获股东大会特别授权，可于特定期间内于香港联交所回购不超过公司已发行H股总数10%的股份。公司目前已发行H股共1.418亿股，按照公告所载比例测算，回购数量最高可达1418万股。泰德医药已于公告列举自2025年6月至2026年5月期间的H股最高及最低股价，期间波动区间大约介于21.04港元至41.72港元之间。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"泰德医药获授权回购不超过已发行股份10%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111257244","title":"泰德醫藥4月股份變動月報表：股本維持不變","url":"https://stock-news.laohu8.com/highlight/detail?id=1111257244","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111257244?lang=zh_tw&edition=fundamental","pubTime":"2026-05-06 16:53","pubTimestamp":1778057615,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司于2026年5月6日发布2026年4月股份变动月报表，披露公司截至2026年4月30日的股本情况。根据公告，公司普通股H股于香港联交所上市，期末已发行H股数量为141,800,000股，每股面值人民币1元，对应已发行股本人民币1.42亿元，与上月末持平。公告显示，报告期内公司未发生新增发行、回购、注销或库藏股变动，现有股本规模保持不变。此外，公司表示已遵守香港联交所《上市规则》及相关法律规定。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629285326","title":"泰德醫藥：2025年淨利潤按年增長267.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2629285326","media":"南方财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629285326?lang=zh_tw&edition=fundamental","pubTime":"2026-04-23 22:52","pubTimestamp":1776955920,"startTime":"0","endTime":"0","summary":"南财智讯4月23日电，泰德医药（03880.HK）公告，截至2025年12月31日止年度，公司总收入为人民币5.70亿元，同比增长28.9%；年内溢利为人民币2.17亿元，同比增长267.3%；每股基本盈利为人民币1.53元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604233716673387.html","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604233716673387.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171857123","title":"泰德醫藥更新2026年3月股份變動月報表，股本增至141,800,000股","url":"https://stock-news.laohu8.com/highlight/detail?id=1171857123","media":"公告速递","labels":["SGX"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1171857123?lang=zh_tw&edition=fundamental","pubTime":"2026-04-08 17:47","pubTimestamp":1775641623,"startTime":"0","endTime":"0","summary":"泰德医药（浙江）股份有限公司（03880）于2026年4月8日披露了2026年3月股份变动月报表。报告期为2026年3月1日至3月31日。\n报告期内，公司已发行股本由73,598,888股增加至141,800,000股，增幅主要源于将68,201,112股非上市股份转换为H股。相应地，截至本月末，非上市股份数量降至0股，公司注册股本总额为人民币141,800,000元。\n无数据显示公司本月有股份购回、注销或库藏股的活动，也未披露与期权或激励计划相关的变动事项。公告显示，公司确认已遵守香港联交所《上市规则》和其他适用的法律法规。\n据公开信息，本份月报表由联席公司秘书吴东澄签署。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03880"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619462645","title":"泰德醫藥(03880.HK)擬3月30日召開董事會會議審批年度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2619462645","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2619462645?lang=zh_tw&edition=fundamental","pubTime":"2026-03-16 23:07","pubTimestamp":1773673621,"startTime":"0","endTime":"0","summary":"格隆汇3月16日丨泰德医药(03880.HK)宣布，董事会会议将于2026年3月30日(星期一)召开，藉以(其中包括)审议及批准公司及其附属公司截至2025年12月31日止年度的年度业绩及其刊发，并考虑派发末期股息之建议(如有)以及处理其他事项。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260316/32072725.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["03880","BK1141"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":31,"code":"91000000","status":"200"}]}}